Among these genes, five genes, including TP53, PIK3CA, CNTNAP5, FBXW7, and NRAS, had higher mutation frequencies in CRC‐I compared with CRA, suggesting their pivotal roles in the progression of CRC (Figures 5B and S1). This evidence concerns the gene TP53 and colorectal carcinoma.